HIM
NTGN

Hillhouse Investment Management’s Neon Therapeutics, Inc. Common Stock NTGN Stock Holding History

Hillhouse Investment Management’s Portfolio NTGN Stock Details NTGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$1.89M Hold
399,308
– – 0.06% 34
2019
Q1 		$2.58M Hold
399,308
– – 0.11% 33
2018
Q4 		$2.01M Sell
399,308
-312,500
-44% -$2.19M 0.15% 22
2018
Q3 		$6.08M Sell
711,808
-1
-0% -$11 0.16% 44
2018
Q2 		$8.97M Buy
+711,809
New +$9.75M 0.15% 42

Other funds holding NTGN

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HMC
Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Hillhouse Investment Management's NTGN Position: Q2 2019 in Review

Hillhouse Investment Management held its Neon Therapeutics, Inc. Common Stock (NTGN) position steady in Q2 2019 at 399,308 shares worth $1.89M. The position accounts for 0.06% of the portfolio, ranked #34.

Hillhouse Investment Management first reported a position in NTGN in Q2 2018 and has held it in 5 quarters since. The position peaked at $8.97M in Q2 2018. 51 funds tracked by Wall St. Rank hold NTGN as of Q2 2019.

  • Hillhouse Investment Management held 399,308 shares of Neon Therapeutics, Inc. Common Stock worth $1.89M as of Q2 2019.
  • Hillhouse Investment Management left its Neon Therapeutics, Inc. Common Stock share count unchanged in Q2 2019.
  • Neon Therapeutics, Inc. Common Stock made up 0.06% of Hillhouse Investment Management's portfolio in Q2 2019, its #34 holding.
  • Hillhouse Investment Management first reported a position in Neon Therapeutics, Inc. Common Stock in Q2 2018 and has held it in 5 quarters since.
  • Hillhouse Investment Management's Neon Therapeutics, Inc. Common Stock position peaked at $8.97M in Q2 2018.
  • 51 funds tracked by Wall St. Rank held Neon Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Hillhouse Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.